Showing BioInteractions for Aminocaproic acid (DB00513)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Aminocaproic acid is a Plasminogen inhibitor | ||
1 | Plasminogen inhibitors | Gabexate, Tranexamic acid |
2 | Plasminogen activators | Alteplase, Anistreplase, Reteplase, Streptokinase, Tenecteplase, Urokinase |
Interacting Group | Interacting Drugs | |
---|---|---|
Aminocaproic acid is a Tissue-type plasminogen activator antagonist | ||
1 | Tissue-type plasminogen activator inhibitors | Conestat alfa, Human C1-esterase inhibitor |
2 | Tissue-type plasminogen activator modulators | Dexibuprofen |
Interacting Group | Interacting Drugs | |
---|---|---|
Aminocaproic acid is a Aldehyde oxidase substrate | ||
1 | Aldehyde oxidase substrates | Allopurinol, Brimonidine, Capmatinib, Famciclovir, Favipiravir, Idelalisib, Lenvatinib, Mercaptopurine, Methotrexate, N-methylnicotinamide, NADH, Pyrazinamide, Urethane, Zaleplon, Ziprasidone, Zonisamide |
2 | Aldehyde oxidase inhibitors | Cyclobenzaprine, Favipiravir, Menadione, Raloxifene |